MINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will MINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

Author: AI Journal

Source: AI Journal

2025/12/23 20:25

BIO$0.04135-3.81%

P$0.0187+2.07%

M$1.3528+0.31%

LIVE$0.00003791-5.20%

VIA$0.0098--%

MINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne’s Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:	David Clair, Vice President, Investor Relations
	david.clair@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-2026-jp-morgan-healthcare-conference-302648108.html

SOURCE Bio-Techne Corporation

Market Opportunity

BIO Protocol Price(BIO)

$0.04135

$0.04135$0.04135

+0.53%

USD

BIO Protocol (BIO) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.